Delivery Order SPE2DB24D2205-SPE2DB25FEGMW
Award Date 8/20/25
Potential Completion Date 8/21/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,249.80 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,344.55 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on June 4, 2025, with a completion date of June 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.9...
- The Defense Logistics Agency awarded a delivery order valued at $12,991.41 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed price arrangement. The contract, valued at $4,363.07, was awarded on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $24,690.56 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for delivery to the Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,352.39 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xifaxan 550 mg tablets (60-count packaging). This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,985.98 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed price terms with an ultimate completion date of August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its Pennsylvania facility. This delivery order...
- The Defense Logistics Agency awarded a $43,495.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). The contract, which represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, carries an ultimate completion date of September 4, 2025, and involves no set-aside designation, indicating competitive award status. Performance will be executed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,434.78 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a gastrointestinal antibiotic commonly used to treat traveler's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xifaxan 550 mg tablets (60-count units) on June 26, 2025, with a ceiling value of $20,364.81 and a firm fixed price structure. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026. The place of performance is located...